your doctor should review all current medicines [16] [17] Realistic expectations for weight loss , including the likelihood of weight regain if treatment is discontinued a pattern observed with other medicines in this class Long-term commitment and monitoring requirements , including regular blood tests (including renal function, HbA1c, and liver enzymes), cardiovascular assessments, and follow-up appointments Pregnancy, breastfeeding, and contraception : Weight-loss medicines are not recommended during pregnancy or breastfeeding
2.3 Data extraction and risk of bias assessment Two independent reviewers (IR and SK) extracted the following data using a pre-tested form: Author name, publication year, country of origin
LV mass was increased in PCD patients
In vivo, GLP-1 has a half-life of only 23 min, preventing its therapeutic utilisation 31,32,33,34,35
Dosing: Determined by your healthcare provider to ensure safety and effectiveness
Zepbound (Tirzepatide) Zepbound is a once-weekly injection that targets two hormones, GLP-1 and GIP, for enhanced weight loss results
